{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:42:37Z","timestamp":1777984957261,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04483-z","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:55:30Z","timestamp":1763135730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Managing paraneoplastic GABABR-related limbic encephalitis in a patient with a small cell lung cancer receiving an Immune-Checkpoint Inhibitor (ICI) therapy: description of a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Mathilde","family":"Cezar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachele","family":"Belletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Polidori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Soive","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Campitiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Olivier","family":"Legros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Egea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Plastino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Benaiteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Tyvaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampaolo","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"4483_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","volume":"12","author":"E Lancaster","year":"2016","unstructured":"Lancaster E. The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol. 2016;12:1\u201313.","journal-title":"J Clin Neurol"},{"issue":"4","key":"4483_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404.","journal-title":"Lancet Neurol"},{"key":"4483_CR3","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3174\/ajnr.A5086","volume":"38","author":"BP Kelley","year":"2017","unstructured":"Kelley BP, Patel SC, Marin HL, Corrigan JJ, Mitsias PD, Griffith B. Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis. Am J Neuroradiol. 2017;38:1070\u20138. https:\/\/doi.org\/10.3174\/ajnr.A5086.","journal-title":"Am J Neuroradiol"},{"key":"4483_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2021.673339","volume":"12","author":"E Sechi","year":"2021","unstructured":"Sechi E, Flanagan EP. Antibody-mediated autoimmune diseases of the CNS: challenges and approaches to diagnosis and management. Front Neurol. 2021;12:1\u201318. https:\/\/doi.org\/10.3389\/fneur.2021.673339.","journal-title":"Front Neurol"},{"issue":"6","key":"4483_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1474-4422(23)00083-2","volume":"22","author":"J Dalmau","year":"2023","unstructured":"Dalmau J, Graus F. Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease. Lancet Neurol. 2023;22(6):529\u201340. https:\/\/doi.org\/10.1016\/S1474-4422(23)00083-2.","journal-title":"Lancet Neurol"},{"key":"4483_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00706","author":"C Hermetter","year":"2018","unstructured":"Hermetter C, Fazekas F, Hochmeister S. Systematic review: syndromes, early diagnosis, and treatment in autoimmune encephalitis. Front Neurol. 2018. https:\/\/doi.org\/10.3389\/fneur.2018.00706.","journal-title":"Front Neurol"},{"issue":"3","key":"4483_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/brain\/91.3.481","volume":"91","author":"JA Corsellis","year":"1968","unstructured":"Corsellis JA, Goldberg GJ, Norton AR. Limbic encephalitis and its association with carcinoma. Brain. 1968;91(3):481\u201396.","journal-title":"Brain"},{"issue":"5","key":"4483_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00234-024-03318-x","volume":"66","author":"F Sanvito","year":"2024","unstructured":"Sanvito F, Pichiecchio A, Paoletti M, Rebella G, Resaz M, Benedetti L, et al. Autoimmune encephalitis: what the radiologist needs to know. Neuroradiology. 2024;66(5):653\u201375. https:\/\/doi.org\/10.1007\/s00234-024-03318-x.","journal-title":"Neuroradiology"},{"issue":"2","key":"4483_CR9","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1097\/RLU.0000000000001076","volume":"41","author":"MdelP C\u00f3zar Santiago","year":"2016","unstructured":"C\u00f3zar Santiago Mdel P, Sanchez Jurado R, Sanz Llorens R, Aguilar Barrios JE, Ferrer Rebolleda J. Limbic encephalitis diagnosed with 18F-FDG PET\/CT. Clin Nucl Med. 2016;41(2):e101-3.","journal-title":"Clin Nucl Med"},{"key":"4483_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00234-006-0069-0","volume":"48","author":"H Urbach","year":"2006","unstructured":"Urbach H, Soeder BM, Jeub M, Klockgether T, Meyer B, Bien CG. Serial MRI of limbic encephalitis. Neuroradiology. 2006;48:380\u20136. https:\/\/doi.org\/10.1007\/s00234-006-0069-0.","journal-title":"Neuroradiology"},{"key":"4483_CR11","doi-asserted-by":"publisher","first-page":"144273","DOI":"10.3389\/fimmu.2024.1442733","volume":"15","author":"D Li","year":"2024","unstructured":"Li D, Zong S, Yao Y, Molenaar PC, Damoiseaux JMCM, Li H, et al. Anti-GABAB receptor encephalitis: clinical and laboratory characteristics, imaging, treatments and prognosis. Front Immunol. 2024;15:144273. https:\/\/doi.org\/10.3389\/fimmu.2024.1442733.","journal-title":"Front Immunol"},{"issue":"11","key":"4483_CR12","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s11910-023-01306-x","volume":"23","author":"R Aoun","year":"2023","unstructured":"Aoun R, Gratch D, Kaminetzky D, Kister I. Immune checkpoint inhibitors in patients with pre-existing neurologic autoimmune disorders. Curr Neurol Neurosci Rep. 2023;23(11):735\u201350. https:\/\/doi.org\/10.1007\/s11910-023-01306-x.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4483_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.576980","author":"A Gill","year":"2019","unstructured":"Gill A, Perez MA, Perrone CM, Bae CJ, Pruitt AA, Lancaster E. A case series of PD-1 inhibitor-associated paraneoplastic neurologic syndromes. J Neuroimmunol. 2019. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.576980.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"4483_CR14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2169\/internalmedicine.4321-24","volume":"64","author":"K Otomo","year":"2025","unstructured":"Otomo K, Fujita M, Sekine R, Sato H, Abe N, Sugaya T, et al. Patient with atezolizumab-induced encephalitis in hepatocellular carcinoma. Intern Med. 2025;64(8):1181\u20137. https:\/\/doi.org\/10.2169\/internalmedicine.4321-24.","journal-title":"Intern Med"},{"issue":"1","key":"4483_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2169\/internalmedicine.7167-21","volume":"61","author":"H Arai","year":"2022","unstructured":"Arai H, Utsu Y, Horio J, Furukawa S, Kikkawa Y. Paraneoplastic opsoclonus-myoclonus syndrome with anti-Hu and anti-SOX-1 antibodies after immune-checkpoint inhibitor treatment combined with chemotherapy in a patient with small-cell lung cancer. Intern Med. 2022;61(1):71\u20134. https:\/\/doi.org\/10.2169\/internalmedicine.7167-21.","journal-title":"Intern Med"},{"issue":"6","key":"4483_CR16","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.3390\/curroncol30060440","volume":"30","author":"AN Alsalem","year":"2023","unstructured":"Alsalem AN, Scarffe LA, Briemberg HR, Aaroe AE, Harerison RA. Neurological complications of cancer immunotherapy. Curr Oncol. 2023;30(6):5876\u201397. https:\/\/doi.org\/10.3390\/curroncol30060440.","journal-title":"Curr Oncol"},{"issue":"7","key":"4483_CR17","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1001\/jamaneurol.2021.0249","volume":"78","author":"R Velasco","year":"2021","unstructured":"Velasco R, Villagr\u00e1n M, Jov\u00e9 M, Sim\u00f3 M, Vilari\u00f1o N, Alemany M, et al. Encephalitis induced by immune checkpoint inhibitors: a systematic review. JAMA Neurol. 2021;78(7):864\u201373. https:\/\/doi.org\/10.1001\/jamaneurol.2021.0249.","journal-title":"JAMA Neurol"},{"key":"4483_CR18","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jnnp-2020-325302","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud H, Probasco J, Irani SR, Ances B, Benavides DR, Bradshaw M, et al. Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management. J Neurol Neurosurg Psychiatry. 2021;92:897\u2013907. https:\/\/doi.org\/10.1136\/jnnp-2020-325302.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"4483_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-019-1542-9","volume":"19","author":"R Longo","year":"2019","unstructured":"Longo R, Wagner M, Savenkoff B, de Castaing MC, Desiro G, tubail Z, et al. A paraneoplastic limbic encephalitis from an anorectal small cell neuroendocrine carcinoma: a case report. BMC Neurol. 2019;19(1):304. https:\/\/doi.org\/10.1186\/s12883-019-1542-9.","journal-title":"BMC Neurol"},{"issue":"3","key":"4483_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000505099","volume":"98","author":"P Uciechowski","year":"2020","unstructured":"Uciechowski P, Dempke WCM. Interleukin-6: a masterplayer in the cytokine network. Oncology. 2020;98(3):131\u20137. https:\/\/doi.org\/10.1159\/000505099.","journal-title":"Oncology"},{"issue":"4","key":"4483_CR21","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","volume":"13","author":"WJ Lee","year":"2016","unstructured":"Lee WJ, Lee ST, Moon J, Sunwoo JS, Byun JI, Lim JA, et al. Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study. Neurotherapeutics. 2016;13(4):824\u201332. https:\/\/doi.org\/10.1007\/s13311-016-0442-6.","journal-title":"Neurotherapeutics"},{"key":"4483_CR22","doi-asserted-by":"publisher","first-page":"keaf006doi","DOI":"10.1093\/rheumatology\/keaf006","volume":"3","author":"NR Goldman","year":"2025","unstructured":"Goldman NR, Nihtyanova SI, Beesley CF, Wells AU, Denton CP, Renzoni EA, et al. Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis. Rheumatol Oxf Engl. 2025;3:keaf006doi. https:\/\/doi.org\/10.1093\/rheumatology\/keaf006.","journal-title":"Rheumatol Oxf Engl"},{"key":"4483_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1271102","volume":"14","author":"R Pandey","year":"2023","unstructured":"Pandey R, Bakay M, Hakonarson H. SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis. Front Immunol. 2023;14:1271102. https:\/\/doi.org\/10.3389\/fimmu.2023.1271102.","journal-title":"Front Immunol"},{"issue":"11","key":"4483_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102390","volume":"18","author":"Y Jamilloux","year":"2019","unstructured":"Jamilloux Y, El Jammal T, Vuitton L, Gerfaud-Valentin M, Kerever S, S\u00e8ve P. JAK inhibitors for the treatment of autoimmune and inflammatory diseases. Autoimmun Rev. 2019;18(11):102390. https:\/\/doi.org\/10.1016\/j.autrev.2019.102390.","journal-title":"Autoimmun Rev"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04483-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04483-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04483-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:55:30Z","timestamp":1763135730000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04483-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4483"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04483-z","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A written informed consent was obtained from the patient for publication of this Case report and any accompanying images. It is available for review by the\n                      Editor-in-Chief\n                      of the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"467"}}